Platelet Activation Inhibitory Signaling

Click on one of the choices in the Explore Pathways box to view a different Platelet pathway.
Integrin alpha 2b beta 3
GPVI
CLEC-2
Src
Csk
Lyn
Fyn
SHIP
CD31/
PECAM-1
ProductsClose
G6b
G6b
ProductsClose
G6b
Shp1,2
PI 3-Kinase
PLC-gamma
alpha-2 Adrenergic R
P2Y12
PTGER3
G alpha i
PTGER2,4
PTGIR
Adenosine A2a,A2b R
VIP R1/VPAC1
G alpha s
PTGER3
G alpha z
Adenylyl Cyclase
cAMP
AMP
PKA
Phosphodiesterase 2,3
Caldesmon
Filamin A
G alpha 13
GPIb
HSP27
ProductsClose
IP3 Receptor
LASP
MAPK
Phosphodiesterase 3A
Rap1
Rap1GAP2
TRPC6
VASP
Nitric Oxide
L-Arginine
ProductsClose
We currently do not offer products for this molecule. Use our Product Suggestion form to enter a request. You will be notified once it becomes available.
eNOS
Citrulline
Nitric Oxide
Soluble
Guanylyl
Cyclase
cGMP
ProductsClose
GMP
ProductsClose
We currently do not offer products for this molecule. Use our Product Suggestion form to enter a request. You will be notified once it becomes available.
Phosphodiesterase 5A
PKG
HSP27
ProductsClose
IP3 Receptor
LASP
Myosin Light
Chain Kinase
MAPK
PI 3-Kinase
Phosphodiesterase 5A
Rap1
Rap1GAP2
Thromboxane A2 R
TRPC6
VASP
Inhibition of
Granule Release
Calcium Release
Integrin Activation
Platelet Activation Inhibitory Signaling

Overview of Inhibitory Signaling in Platelets

Unrestricted platelet activation can lead to life threatening thrombosis. In order to maintain control of this process, multiple steps in the platelet activation are regulated by cell surface receptors that block activation signals and by receptors that induce both activating and inhibitory signaling. Healthy vascular endothelial cells release nitric oxide and prostaglandin I2 (prostacyclin) into the blood where they maintain platelet quiescence by blocking granule release and integrin activation.